ClinConnect ClinConnect Logo
Search / Trial NCT04406038

Study of the Spread of COVID-19 in Saint Petersburg, Russia

Launched by EUROPEAN UNIVERSITY AT ST. PETERSBURG · May 26, 2020

Trial Information

Current as of May 12, 2025

Completed

Keywords

Seroprevalence Covid 19 Sars Cov 2

ClinConnect Summary

At least 1 000 individuals, 18 years old and older, are randomly sampled using random digit dialing from the population of Saint Petersburg, Russia. Random sampling is performed by a survey company on the list of mobile phone numbers with designated geography prefixes of St. Petersburg. The baseline questionnaire for computer-assisted telephone interview includes travel history, medical history, and socio-economic status of the respondents. Sampled individuals are then invited to the clinic for blood sampling, their refusal to participate is recorded. Collected blood samples are used for SA...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Individuals sampled from the population of Saint Petersburg, Russia using random digit dialling.
  • Subjects aged 18 and older of both genders.
  • Asymptomatic at the time of blood draw.
  • Written informed consent for a blood draw, SARS-COV-2 antibody test, and data collection.
  • Exclusion Criteria:
  • Presence of fever or cough or respiratory distress at the time of blood test not attributable to other known chronic disease.
  • Age under 18.
  • Any health condition that may be a contraindication towards blood sampling in out-patient clinic.
  • Residence in Kolpinskiy, Kurortniy, Krasnoselsky, Kronshtadtskiy, Petrodvorcoviy, Pushkinskiy districts of St. Petersburg.

About European University At St. Petersburg

The European University at St. Petersburg is a prestigious academic institution dedicated to advancing research and education in the social sciences and humanities. As a sponsor of clinical trials, the university leverages its expertise to facilitate innovative studies aimed at enhancing public health and medical knowledge. By fostering interdisciplinary collaboration and adhering to rigorous ethical standards, the university supports the development of evidence-based interventions and contributes to the global body of clinical research. Its commitment to academic excellence and research integrity positions it as a key player in the advancement of healthcare solutions.

Locations

Saint Petersburg, , Russian Federation

Patients applied

0 patients applied

Trial Officials

Lubov Barabanova, MD

Principal Investigator

Clinic "Scandinavia"

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials